Literature DB >> 32297096

Cone-beam computed tomography for organ motion evaluation in locally advanced rectal cancer patients.

Consuelo Rosa1,2, Luciana Caravatta3, Monica Di Tommaso1, David Fasciolo1, Lucrezia Gasparini1, Fiorella Cristina Di Guglielmo1, Antonietta Augurio1, Annamaria Vinciguerra1, Claudio Vecchi4, Domenico Genovesi1,2.   

Abstract

PURPOSE: Due to a reported dose-response relationship in rectal cancer radiotherapy, a greater interest in dose intensification on small boost volume arises. Considering the need of an appropriate target movements evaluation, this retrospective study aimed to use cone-beam computed tomography (CBCT) for GTV and mesorectum organ motion (OM) evaluation, in locally advanced rectal cancer (LARC) patients treated with neoadjuvant chemo-radiotherapy, in prone and supine position.
METHODS: Thirty-two LARC patients were analyzed. GTV and mesorectum were delineated on MRI co-registrated with CT simulation. GTV and mesorectum OM was estimated on all CBCTs, performed during treatment, co-registrated with CT simulation. OM evaluation was obtained, as mean shift in left and right (L-R), postero-anterior (P-A) and cranio-caudal (Cr-C) directions. Volumes variability was calculated by DICE index.
RESULTS: A total of 296 CBCTs were analyzed. Mean shifts of the GTV and mesorectum in prone position were - 0.16 cm and 0.15 cm in L-R direction, 0.28 cm and - 0.40 cm in P-A direction, and 0.14 cm and - 0.21 cm, in Cr-C direction; for supine position the mean shifts of the GTV were - 0.10 cm and 0.17 cm in R-L direction, 0.26 cm and - 0.23 cm in A-P direction, 0.09 cm and - 0.11 cm in Cr-C direction. Mean DICE index for GTV and mesorectum was 0.74 and 0.86, in prone position, and 0.78 and 0.89 in supine position, respectively.
CONCLUSION: GTV and mesorectum OM was less than 4 mm in all directions in both positions, with a 1 mm less deviation in supine position. CBCTs resulted effective for OM assessment, and it could be an appropriate method for the implementation on an intensification treatment.

Entities:  

Keywords:  Cone-beam computed tomography; Dose intensification; Organ motion; Radiotherapy; Rectal cancer

Year:  2020        PMID: 32297096     DOI: 10.1007/s11547-020-01193-z

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  17 in total

1.  Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels.

Authors:  M Teresa Guerrero Urbano; Anthony J Henrys; Elisabeth J Adams; Andrew R Norman; James L Bedford; Kevin J Harrington; Christopher M Nutting; David P Dearnaley; Diana M Tait
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-07-01       Impact factor: 7.038

2.  Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Authors:  Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

3.  Bowel exposure in rectal cancer IMRT using prone, supine, or a belly board.

Authors:  Jasper Nijkamp; Barry Doodeman; Corrie Marijnen; Andrew Vincent; Corine van Vliet-Vroegindeweij
Journal:  Radiother Oncol       Date:  2011-06-30       Impact factor: 6.280

4.  International consensus guidelines on Clinical Target Volume delineation in rectal cancer.

Authors:  Vincenzo Valentini; Maria Antonietta Gambacorta; Brunella Barbaro; Giuditta Chiloiro; Claudio Coco; Prajnan Das; Francesco Fanfani; Ines Joye; Lisa Kachnic; Philippe Maingon; Corrie Marijnen; Samuel Ngan; Karin Haustermans
Journal:  Radiother Oncol       Date:  2016-08-12       Impact factor: 6.280

5.  Biological image-guided radiotherapy in rectal cancer: challenges and pitfalls.

Authors:  Sarah Roels; Pieter Slagmolen; Johan Nuyts; John A Lee; Dirk Loeckx; Frederik Maes; Vincent Vandecaveye; Sigrid Stroobants; Nadine Ectors; Freddy Penninckx; Karin Haustermans
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-14       Impact factor: 7.038

6.  Preoperative intensity-modulated and image-guided radiotherapy with a simultaneous integrated boost in locally advanced rectal cancer: report on late toxicity and outcome.

Authors:  Benedikt Engels; Nele Platteaux; Robbe Van den Begin; Thierry Gevaert; Alexandra Sermeus; Guy Storme; Dirk Verellen; Mark De Ridder
Journal:  Radiother Oncol       Date:  2013-11-12       Impact factor: 6.280

7.  Target volume shape variation during hypo-fractionated preoperative irradiation of rectal cancer patients.

Authors:  Jasper Nijkamp; Rianne de Jong; Jan-Jakob Sonke; Peter Remeijer; Corine van Vliet; Corrie Marijnen
Journal:  Radiother Oncol       Date:  2009-05-18       Impact factor: 6.280

Review 8.  Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: a systematic review and meta-analysis.

Authors:  Johannes Peter Maarten Burbach; Annemarie Maria den Harder; Martijn Intven; Marco van Vulpen; Helena Marieke Verkooijen; Onne Reerink
Journal:  Radiother Oncol       Date:  2014-10-01       Impact factor: 6.280

9.  Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma.

Authors:  Henry Mok; Christopher H Crane; Matthew B Palmer; Tina M Briere; Sam Beddar; Marc E Delclos; Sunil Krishnan; Prajnan Das
Journal:  Radiat Oncol       Date:  2011-06-08       Impact factor: 3.481

10.  Analysis of motion of the rectum during preoperative intensity modulated radiation therapy for rectal cancer using cone-beam computed tomography.

Authors:  Hideomi Yamashita; Ryousuke Takenaka; Akira Sakumi; Akihiro Haga; Kuni Otomo; Keiichi Nakagawa
Journal:  Radiat Oncol       Date:  2015-01-08       Impact factor: 3.481

View more
  4 in total

1.  Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery.

Authors:  Valerio Nardone; Alfonso Reginelli; Roberta Grassi; Giovanna Vacca; Giuliana Giacobbe; Antonio Angrisani; Alfredo Clemente; Ginevra Danti; Pierpaolo Correale; Salvatore Francesco Carbone; Luigi Pirtoli; Lorenzo Bianchi; Angelo Vanzulli; Cesare Guida; Roberto Grassi; Salvatore Cappabianca
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

Review 2.  The Role of Magnetic Resonance Enterography in Crohn's Disease: A Review of Recent Literature.

Authors:  Marysol Biondi; Eleonora Bicci; Ginevra Danti; Federica Flammia; Giuditta Chiti; Pierpaolo Palumbo; Federico Bruno; Alessandra Borgheresi; Roberta Grassi; Francesca Grassi; Roberta Fusco; Vincenza Granata; Andrea Giovagnoni; Antonio Barile; Vittorio Miele
Journal:  Diagnostics (Basel)       Date:  2022-05-15

3.  Radiomics and Machine Learning Analysis Based on Magnetic Resonance Imaging in the Assessment of Colorectal Liver Metastases Growth Pattern.

Authors:  Vincenza Granata; Roberta Fusco; Federica De Muzio; Carmen Cutolo; Mauro Mattace Raso; Michela Gabelloni; Antonio Avallone; Alessandro Ottaiano; Fabiana Tatangelo; Maria Chiara Brunese; Vittorio Miele; Francesco Izzo; Antonella Petrillo
Journal:  Diagnostics (Basel)       Date:  2022-04-29

4.  Linear Tumor Regression of Rectal Cancer in Daily MRI during Preoperative Chemoradiotherapy: An Insight of Tumor Regression Velocity for Personalized Cancer Therapy.

Authors:  Soo-Yoon Sung; Sea-Won Lee; Ji Hyung Hong; Hye Jin Kang; So Jung Lee; Myungsoo Kim; Ji-Hoon Kim; Yoo-Kang Kwak
Journal:  Cancers (Basel)       Date:  2022-08-01       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.